Delivery Order SPE2DB25D7067-SPE2DB25FSVXU
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,887.66 to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 30-gram units. This firm fixed price, non-competitive delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The pharmaceutical product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,534.08 by the Defense Logistics Agency on August 19, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram quantities. The contract utilizes firm fixed pricing and carries an ultimate completion date of August 20, 2025. This competitively awarded delivery order, which includes no set-aside designation, is issued under AmerisourceBergen's...
- This is a $1,139.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 100 gram tubes of Pimecrolimus 1% cream. The contract has an ultimate completion date of July 3, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
- This firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution company. The contract provides for the delivery of PIMECROLIMUS 1% CREAM 60GM, a pharmaceutical product, with a potential value of $1,378.27 and a completion date of March 8, 2024. This award is not associated with any set-aside designation....
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,277.38 contract is for the delivery of Pimecrolimus 1% Cream, 100 grams. The contract has a performance period through March 4, 2024 and was awarded on March 1, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pimecrolimus 1% Cream in 60-gram tubes, with a ceiling value of $1,759.49 and a completion date of March 14, 2025. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, located in Conshohocken, Pennsylvania. The contract has a potential value of $1,008.72 and a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor providing 4563731900 - Pimecrolimus 1% Cream 30GM to DLA Troop Support Medical facilities in support of military treatment programs. This...
- The Defense Logistics Agency Troop Support Medical awarded a $1,226.86 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for Pimecrolimus 1% Cream 30gm. The prime contractor will deliver the pharmaceutical product to the place of performance in Conshohocken, Pennsylvania by the period of performance end date of September 26, 2023. The Defense Logistics Agency supports Department of Defense health care programs and supplies medical material to military...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Pimecrolimus 1% Cream 30g, a topical medication, and has a ceiling value of $1,539.00. This is a Firm Fixed Price Delivery Order contract with a completion date of November 29, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Pimecrolimus 1% Cream 30GM, a pharmaceutical product, with a ceiling value of $1,322.25 and a period of performance through March 14, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSVXUDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in a 30-gram quantity, valued at $20,510.86. This delivery order, issued on September 11, 2025, represents a firm fixed-price contract with an ultimate completion date of September 12, 2025. The contract carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. This prime contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.5k | 9/11/25 |